C.H. Riley, III,

Regional Director, Operations
C.H. Riley, III, Regional Director, Operations

C.H. Riley, III, Regional Director, Operations, joined Triad Isotopes in 2007 to oversee the quality program for Triad Isotopes' Positron Emissions Tomography drug manufacturing facility located in Charleston, SC. Among his many responsibilities are employee training, supervision of the engineering team to promote a safe and efficient operation, instrument maintenance, cGMP compliance and oversight, record keeping and batch review,  and ensuring the site complies with regulations set forth in 21 CFR 212.

A Board Certified Nuclear Pharmacist and Radiation Safety Officer, C.H. is active on behalf of Triad Isotopes in many clinical trials and research studies, most recently flurpiridaz F-18 injection with Lantheus Medical Imaging. He was also a lead team member involved in designing the ISO 8 clean room for pharmacy and manufacturing functions, as well as integral in developing a novel synthesis for F-18 fallypride – a study presented at the 2013 World Molecular Imaging meeting in Savannah, GA, and the 2013 Biomedical Engineering Society annual meeting in Seattle, WA.

In addition to being a seasoned presenter and educator, C.H. is a member of the American Pharmacy Association, the Society of Nuclear Medicine, the South Carolina Society of Nuclear Medicine, and the South Carolina Pharmacist Association.